Weekly Recap: Evonik rejects BASF bid and raises full-year targets

Evonik Industries AG (EVK) rejected BASF's €24-per-share offer, valuing it at €11.18 billion, citing an insufficient price. The company raised its full-year targets despite a weakening German chemical sector, according to Reuters.

Original reporting
Published Nov 16, 2026, 5:00 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 16, 2026, 8:07 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Weekly Recap: Evonik rejects BASF bid and raises full-year targets — source image
Decision brief

The 30-second read

$BAS.DEBearishHigh
01

Why it matters

The rejection removes a premium acquisition premium, likely prompting short‑term price declines for both parties and prompting investors to re‑evaluate sector exposure.

02

Market read

Primary M&A news with material valuation impact; immediate trading relevance for both German chemical stocks.

03

What to watch

Potential regulatory scrutiny or integration challenges that may have motivated Evonik's decision.

Relevance 8/10Novelty 8/10Timing: immediate market reaction

Background

The article summarizes a recent M&A negotiation where Evonik turned down BASF's improved bid and simultaneously raised its own full‑year guidance amid a weakening German chemicals market.

Company-level read

Ticker impact

$BAS.DEBearishHigh confidence
Context

BASF's improved €24-per-share offer was turned down by Evonik, halting its acquisition attempt.

Expected impact

downward pressure from the market pricing in the bid failure

Evidence & confidence

The rejection of a multi‑billion‑euro offer is a material negative for BASF's M&A outlook.

Market effects

German chemicals sector may see broader valuation adjustments as the deal fallout raises M&A uncertainty.

European markets could experience modest downside pressure on related chemical stocks.

Limited to chemicals sector; no major global macro impact.

Counterpoint

If Evonik can secure better terms later, the rejection may be seen as a disciplined move, potentially supporting the stock long term.

Key entities

  • Evonik Industries AG

    German chemicals producer, ticker EVK.DE.

  • BASF SE

    World's largest chemical company, ticker BAS.DE.

Related articles

$BAS.DEMed

Evonik shares rise on report BASF prepares renewed takeover offer

BASF (BASFn) is reportedly preparing a renewed takeover offer for Evonik (EVKn) after an earlier €11 billion bid was rejected. BASF is seeking input from German lawmakers and stakeholders to address regulatory and political concerns. Evonik's shares rose 3.3%, while BASF's fell 2.2% on the news. According to Bloomberg, BASF is offering structural guarantees to secure support for the deal.